Filtered By:
Countries: USA Health

This page shows you your search results in order of date. This is page number 7.

Order by Relevance | Date

Total 380 results found since Jan 2013.

Infant and child formula shortages: now is the time to prevent recurrences
Am J Clin Nutr. 2022 May 17:nqac149. doi: 10.1093/ajcn/nqac149. Online ahead of print.ABSTRACTAn acute shortage of infant formulas in the United States occurred in early 2022, exacerbating a longer-standing less severe shortage over the last several years. The shortage has been particularly problematic for specialized formulas such as those needed for infants and children with food allergies, intestinal failure, kidney disease, and metabolic disorders. Although undoubtedly the magnitude of the shortage will abate over time, it has affected many children and caused tremendous distress for thousands of families. We propose a...
Source: The American Journal of Clinical Nutrition - May 17, 2022 Category: Nutrition Authors: Steven A Abrams Christopher P Duggan Source Type: research

The Tick That Causes a Meat Allergy Is on the Move
The lone star tick can trigger an allergic reaction to red meat in those bitten. Now this arachnid ’s territory is expanding.
Source: NYT Health - May 13, 2022 Category: Consumer Health News Authors: Livia Albeck-Ripka Tags: Ticks (Insects) Lyme Disease Global Warming Deer Allergies Delaware United States Source Type: news

Johnson & Johnson Updates U.S. COVID-19 Vaccine Fact Sheet
NEW BRUNSWICK, NJ, May 5, 2022 - Our number one priority is the safety and well-being of those who use the Johnson & Johnson COVID-19 vaccine. Johnson & Johnson, in close coordination with the U.S. Food and Drug Administration (FDA), has updated its U.S. COVID-19 Vaccine Fact Sheet to increase awareness about the risk of thrombosis with thrombocytopenia syndrome (TTS), a rare but potentially life-threatening condition. Language about the risk of TTS has been added to the first page of the Fact Sheet to increase its prominence. Following the update to the Fact Sheet, the Johnson & Johnson COVID-19 vaccine is now...
Source: Johnson and Johnson - May 5, 2022 Category: Pharmaceuticals Source Type: news

The Economic Burden of Food Allergy: What We Know and What We Need to Learn
AbstractPurpose of ReviewFood allergy management and treatment require dietary modification, are associated with significant burdens, and affect food choices and behaviours. Emerging therapies, such as oral immunotherapy (OIT), provide a glimmer of hope for those living with the condition. Some burdens have received substantial focus, whereas many knowledge gaps on the significance of other impacts, including economic burden, remain.Recent FindingsEvidence from many countries, but disproportionately from the United States, supports that food allergy carries significant healthcare and societal costs. Early introduction for ...
Source: Current Treatment Options in Allergy - April 28, 2022 Category: Allergy & Immunology Source Type: research

Health Disparities in Pediatric Food Allergy
CONCLUSION: Racial, ethnic, and socioeconomic disparities in food allergy among children in the United States are evident and negatively affect the outcomes of children with food allergies. Active efforts to decrease racial and socioeconomic disparities through education, research, and advocacy will be important to help improve health outcomes in food allergy for all children, regardless of their race, ethnicity, or socioeconomic status.PMID:35476967 | DOI:10.1016/j.anai.2022.04.022
Source: Annals of Allergy, Asthma and Immunology - April 27, 2022 Category: Allergy & Immunology Authors: Elizabeth Tepler Katelyn H Wong Gary K Soffer Source Type: research

Treat or Refer? New Primary Care Flow Diagrams for Allergy Patients Treat or Refer? New Primary Care Flow Diagrams for Allergy Patients
A new set of flow diagrams aims to help primary care providers in Europe, the United States, and elsewhere treat patients who have allergies.Medscape Medical News
Source: Medscape Allergy Headlines - April 7, 2022 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

The United States Drug Allergy Registry: A Prospective Longitudinal Cohort Study of Patients Tested for Drug Allergies
Drug allergy mislabeling negatively impacts clinical care and public health while preventing scientific advancements related to drug hypersensitivity. Given that single site US studies lack power and generalizability, we aimed to assemble the first multi-site US prospective longitudinal cohort of patients tested for drug allergies.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Kimberly Blumenthal, Allison Ramsey, Upeka Samarakoon, Iris Otani, Alexei Gonzalez-Estrada, Aleena Banerji, Anne Liu, Paige Wickner, Cosby Stone, Miguel Park, Christian Mancini, Allen Judd, Catherine Ahola, Xiaoqing Fu, Yuqing Zhang, Karen Donelan, S Shah Source Type: research

Allergic Reactions During Travel Among Individuals With IgE-mediated Food Allergy
Although IgE-mediated food allergies affect 7.6% of children and 9% of adults in the United States, there is limited information on the prevalence and characteristics of allergic reactions to food during travel. Understanding the reactions that occur during travel will provide at-risk passengers and carriers with the necessary information to create measures to prevent and manage these emergencies.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Beatriz Martinez-Flores, Brit Trogen, Anna Nowak-Wegrzyn, Joseline Cruz Vasquez Source Type: research

Johnson & Johnson Statement on its COVID-19 Vaccine Following CDC ACIP Meeting
NEW BRUNSWICK, N.J., December 16, 2021 – Johnson & Johnson remains confident in the overall positive benefit-risk profile of its COVID-19 vaccine. Studies have shown that the Johnson & Johnson COVID-19 vaccine generates strong antibody and cellular immune responses [i] and long-lasting immune memory[ii] and breadth of protection across variants. In addition, a growing body of evidence is revealing the strength of protection of our vaccine as a booster to either the Janssen COVID-19 vaccine or a different authorized or approved COVID-19 vaccine, both in terms of its efficacy and durability.[iii], [iv], [v], [vi], ...
Source: Johnson and Johnson - December 16, 2021 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine
NEW BRUNSWICK, N.J., December 15, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a Positive Opinion for use of the Company’s COVID-19 vaccine as a booster for adults aged 18 and older at least two months after primary vaccination with a single-shot of the Johnson & Johnson COVID-19 vaccine, and as a ‘mix and match’ booster following primary vaccination with an approved two-shot mRNA COVID-19 vaccine regimen (known as heterologous boosting). “We are pleased with today’s Positiv...
Source: Johnson and Johnson - December 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

To mix or not to mix in allergy immunotherapy vaccines
Purpose of review European and US allergists generally do not agree on the approach to subcutaneous allergy immunotherapy in patients with multiple allergies. The North American approach is to treat with a mixture that contains all the allergen extracts to which the patient has evident clinical sensitivity, whereas the European approach is to select for treatment the one or at the most two allergens that are clinically most important for the patient. Recent findings Recent society guidelines continue to recommend these differing practices of treating the polyallergic patient and reviews of prescribing practices ...
Source: Current Opinion in Allergy and Clinical Immunology - November 8, 2021 Category: Allergy & Immunology Tags: IMMUNOTHERAPY AND NEW TREATMENTS: Edited by Giovanni Passalacqua and Robert Bush Source Type: research